Citation

L. Zhou, Doug Kitch, M.S., Scott Evans, Ph.D., Peter Hauer, M.D., S. Raman, B.S., G. J. Ebenezer, M.B.B.S., Mariana Gerschenson, Ph.D., Christina M. Marra, M.D., Victor G. Valcour, M.D., Ramon Diaz-Arrastia, M.D., Ph.D., Karl Goodkin, M.D., Ph.D., Linda L. Millar, B.S., Sharon L. Shriver, R.Ph., M.S., David M. Asmuth, M.D., David B. Clifford, M.D., David M. Simpson, M.D., Justin C. McArthur, M.B.B.S., M.P.H. Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy. Neurology. 2007 Jun 12; 68(24):2113-9.

Citation

Nimalie D. Stone, Shelia B. Dunaway, M.D., Charles Flexner, M.D., Camlin Tierney, Ph.D., Gary B. Calandra, Ph.D., M.D., F.A.C.P., Stephen L. Becker, M.D., Ying-Jun Cao, Ilene P. Wiggins, R.N., Jeanne Conley, R.N., B.S.N., Ron T. MacFarland, Ph.D., Jeong-Gun Park, Ph.D., Christina M. Lalama, M.S., Sally Snyder, B.S., Beatrice A. Kallungal, B.S., Karin L. Klingman, M.D., Craig Hendrix, M.D., M.C. Multiple dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects. Antimicrobial Agents and Chemotherapy. 2007 Jul 01; 51(7):2351-8.

Citation

Margaret James Koziel, M.D., Marion G. Peters, M.D. Viral hepatitis in HIV infection. New England Journal of Medicine. 2007 Apr 05; 356(14):47-56.

Citation

Charles Flexner, M.D. HIV drug development: the next 25 years. Nature Reviews Drug Discovery. 2007 Dec 01; 6(12):959-66.

Citation

B. Healy, Victor DeGruttola, Sc.D. Hidden Markov models for settings with interval-censored transition times and uncertain time origin: application to HIV genetic analyses. Biostatistics. 2007 Apr 01; 8(2):438-52.

Citation

Roger Paredes, Vincent C. Marconi, Thomas B. Campbell, M.D., Daniel R. Kuritzkes, M.D. Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations. Journal of Virological Methods. 2007 Dec 01; 146(1-2):136-46.

Citation

Heather Ribaudo, Ph.D., Daniel R. Kuritzkes, M.D., Roy (Trip) Gulick, M.D., M.P.H. A comparison of three initial antiretroviral AIDS regimens. New England Journal of Medicine. 2007 Sep 06; 357(10):1056-7.

Citation

Scott Evans, Ph.D. When and how can endpoints be changed after initiation of a randomized clinical trial?. Public Library of Science Clinical Trials. 2007 Apr 13; 2(4):e18.

Citation

Brian Wells Pence, Ph.D., Susan Reif, Ph.D., M.S.W, Kathryn Whetten, Ph.D., M.P.H., Jane Leserman, Ph.D., Dalene Stangl, Ph.D., Marvin Swartz, M.D., Nathan Thielman, M.D., M.P.H., Michael J. Mugavero, M.D., M.H.S. Minorities, the poor and survivors of abuse: HIV-infected patients in the US deep south. Journal of the Southern Medical Association. 2007 Nov 01; 100(11):1114-22.

Citation

Susan C. Morpeth, MB ChB, DTM&H, John A. Crump, MB ChB, DTM&H, Humphrey J. Shao, M.D., Habib O. Ramadhani, M.D., Peter R. Kisenge, M.D., MMED, Cindy A. Moylan, Susanna Naggie, L. Brett Caram, Keren Z. Landman, Noel E. Sam, Dafrosa K. Itemba, B.A., John F. Shao, M.D., Ph.D., John Alexander Bartlett, M.D., Nathan Thielman, M.D., M.P.H. Predicting CD4 lymphocyte count <200 cells/mm3 in an HIV type 1-infected African population. AIDS Research and Human Retroviruses. 2007 Oct 01; 23(10):1230-6.